Big Move For Kymera Therapeutics, Inc.

Mon, Dec 08, 2025 at 07:33 PM

Kymera Therapeutics, Inc. (KYMR:NASDAQ) shot up at $94.3, a gain of 41.5%. On Mon, Dec 08, 2025, KYMR:NASDAQ hit a New 2-Week High of $94.3. The stock got featured on our News Catalysts scanner on Mon, Dec 08, 2025 at 05:54 PM in the 'PUBLIC OFFERING' category. From Mon, Nov 24, 2025, the stock recorded 77.78% Up Days and 60.00% Green Days

About Kymera Therapeutics, Inc. (KYMR:NASDAQ)

Kymera Therapeutics Inc is a biotechnology company pioneering a transformative new approach to treating previously untreatable diseases.

Top 10 Gainers:

Top Wealth Group Holding Limited (TWG:NASDAQ), 266.22%
Smart for Life, Inc. (SMFL:NASDAQ), 228.57%
Orangekloud Technology Inc. (ORKT:NASDAQ), 147.64%
Wave Life Sciences Ltd. (WVE:NASDAQ), 147.26%
Cemtrex, Inc. (CETX:NASDAQ), 129.64%
WEBUY GLOBAL LTD. (WBUY:NASDAQ), 106.09%
Structure Therapeutics Inc. (GPCR:NASDAQ), 102.49%
Biodexa Pharmaceuticals Plc (BDRX:NASDAQ), 74.6%
Fulcrum Therapeutics, Inc. (FULC:NASDAQ), 45.96%
Kymera Therapeutics, Inc. (KYMR:NASDAQ), 41.55%